Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths.
Journal
Journal of addiction medicine
ISSN: 1935-3227
Titre abrégé: J Addict Med
Pays: Netherlands
ID NLM: 101306759
Informations de publication
Date de publication:
28 Sep 2023
28 Sep 2023
Historique:
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
aheadofprint
Résumé
In the midst of the opioid overdose crisis, local jurisdictions face a choice of public health interventions. A significant barrier when considering evidence-based practices (EBPs) is the lack of information regarding their implementation cost. This protocol paper provides the methodological foundation for the economic cost evaluations of community-wide strategies on the scale of a national study. It can serve as a resource for other communities, local policymakers, and stakeholders as they consider implementing possible public health strategies in their unique settings. We present a protocol that details (1) the process of identifying, reviewing, and analyzing individual strategies for study-funded and non-study-funded costs; (2) prospective costing tool designation, and; (3) data collection. To do this, we set up working groups with community stakeholders, reviewed financial invoices, and surveyed individuals with detailed knowledge of their community implementation. There were 3 main challenges/limitations. The first was the lack of a standard structure for documenting nonfunded costs associated with each strategy. The second was the need for timely implementation of cost data. The third was generalizability because our study designed its strategies for selected communities due to their high opioid overdose mortality rates. Future steps include more tailored questions to ask during the categorization/filter process and establishing realistic expectations for organizations regarding documenting. Data collected will provide a critical methodological foundation for costing large community-based EBP strategies and provide clarity for stakeholders on the cost of implementing EBP strategies to reduce opioid overdose deaths.
Identifiants
pubmed: 37768777
doi: 10.1097/ADM.0000000000001218
pii: 01271255-990000000-00230
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDA NIH HHS
ID : P30 DA040500
Pays : United States
Informations de copyright
Copyright © 2023 American Society of Addiction Medicine.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Death Rate Maps & Graphs. Drug Overdose. CDC Injury Center. Available at: https://www.cdc.gov/drugoverdose/deaths/index.html. Published June 2, 2022. Accessed June 27, 2022.
The Full Cost of the Opioid Crisis: $2.5 Trillion Over Four Years—The White House. Accessed June 27, 2022. https://trumpwhitehouse.archives.gov/articles/full-cost-opioid-crisis-2-5-trillion-four-years/.
Luo F, Li M, Florence C. State-level economic costs of opioid use disorder and fatal opioid overdose—United States, 2017. Morb Mortal Wkly Rep. 2021;70(15):541–546.
Chandler RK, Villani J, Clarke T, et al. Addressing opioid overdose deaths: The vision for the HEALing Communities Study. Drug Alcohol Depend. 2020;217:108329.
Walley AY, Doe-Simkins M, Quinn E, et al. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat. 2013;44(2):241–247.
Winhusen T, Walley A, Fanucchi LC, et al. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study. Drug Alcohol Depend. 2020;217:108325.
Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. 2020:156. Published online. Available at: https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf. Accessed September 21, 2023.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Medication-Assisted Treatment for Opioid Use Disorder Medications for Opioid Use Disorder Save Lives. Washington, DC: National Academies Press (US), 2019. Available at: http://www.ncbi.nlm.nih.gov/books/NBK538936/. Accessed June 27, 2022.
Aarons GA, Fettes DL, Hurlburt MS, et al. Collaboration, negotiation, and coalescence for interagency-collaborative teams to scale-up evidence-based practice. J Clin Child Adolesc Psychol. 2014;43(6):915–928.
Linas BP, Savinkina A, Madushani RWMA, et al. Projected estimates of opioid mortality after community-level interventions. JAMA Netw Open. 2021;4(2):e2037259.
The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices—ScienceDirect. Available at: https://www.sciencedirect.com/science/article/pii/S0376871620305007?via%3Dihub. Accessed June 27, 2022.
Oesterle S, Kuklinski MR, Hawkins JD, et al. Long-term effects of the communities that care trial on substance use, antisocial behavior, and violence through age 21 years. Am J Public Health. 2018;108(5):659–665.
Aldridge AP, Barbosa C, Barocas JA, et al. Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study. Drug Alcohol Depend. 2020;217:108336.
Bowser DM, Henry BF, McCollister KE. Cost analysis in implementation studies of evidence-based practices for mental health and substance use disorders: A systematic review. Implement Sci. 2021;16(1):26.
Sprague Martinez L, Rapkin BD, Young A, et al. Community engagement to implement evidence-based practices in the HEALing Communities Study. Drug Alcohol Depend. 2020;217:108326.
Lefebvre RC, Chandler RK, Helme DW, et al. Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing Communities Study. Drug Alcohol Depend. 2020;217:108338.
Campbell CI, Saxon AJ, Boudreau DM, et al. PRimary care Opioid Use Disorders treatment (PROUD) trial protocol: A pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021;16(1):9.
French MT, Dunlap LJ, Zarkin GA, et al. A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat. 1997;14(5):445–445.
Walters ST, Chandler RK, Clarke T, et al. Modifications to the HEALing Communities Study in response to COVID-19 related disruptions. Drug Alcohol Depend. 2021;222:108669.